We are monitoring the impact of COVID-19 on Asia Pacific Psychiatry Therapies Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4356
Share on
Share on

Asia Pacific Psychiatry Therapies Market Research Report – Segmented By Type, Type Of Medication, Type Of Therapy and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Size, Share, Growth, Trends and Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4356
Pages: 141

APAC Psychiatry Therapies Market Size (2021 to 2026)

The size of the Psychiatry Therapies Market in the Asia Pacific is estimated to expand at a high rate from 2021 to 2026.

Psychiatry is a branch of medicine that deals with mental illnesses and treats them through pharmaceutical therapy. In addition to drug therapy, psychiatrists use several psychosocial treatments to help patients. The modern Asian Pacific population is increasingly focused on work and life outside of themselves. As a result, people have more mental health problems than ever before, and self-care is neglected.

The increase in the frequency of mental diseases, the rise in the geriatric population, and the expansion of mental health awareness programs are a few factors accelerating the psychiatry therapies market in the APAC region. Furthermore, the mental health market is rising due to increased awareness of mental diseases due to education and campaigning for tremendous respect for human rights and less stigma.

According to the World Health Organization, mental illness affects one out of every four people. Given the growth in work pressure in the Asia Pacific, this trend is expected to continue. People are devoting less time to themselves, thus affecting their mental health. Mental treatment should be sought out more regularly in the future, given the expanding needs of the Asia Pacific workforce.

Individuals with poor mental health are at risk due to the pandemic, which includes an increase in mental illness, disruption of treatment, medications, and lifeline support services, as well as a negative impact on the market. In addition, a shortage of competent experts in rural areas, increased public health awareness, healthcare infrastructure, and an increase in the number of patients with fewer medical facilities are all further estimated to be limiting the market.

This research report on the Asia Pacific psychiatry therapies market has been segmented and sub-segmented into the following categories:

By Psychology Type: 

  • Social Psychology
  • Abnormal Psychology
  • Biological Psychology
  • Others

By Type of Medication: 

  • Antidepressants
  • Antipsychotics
  • Depressants
  • Anxiolytics
  • Mood Stabilisers
  • Stimulants
  • Others

By Type of Therapy: 

  • Counseling
  • Cognitive Behavioural Therapy
  • Family Therapy
  • Psychotherapy
  • Group Therapy
  • Relationship Counselling
  • Interpersonal Therapy
  • Behavioral Activation
  • Others

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regionally, Asia Pacific has the third-largest market for psychiatry therapy globally by share. It is also the fastest-growing region globally, owing to factors such as rising awareness about mental health and changing lifestyles. In addition, factors such as the growing prevalence of psychological ailments and stress levels are expected to result in the growth of this market.

Asia Pacific countries are predicted to develop at the fastest rate in this market as people become more conscious of the importance of mental health. Regional governments are also in charge of large-scale healthcare provision for their citizens. In the future, these locations are expected to provide psychiatric counseling, among other services.

Furthermore, specific countries, such as India and China, are investing in cutting-edge technology and telecommunications and hiring more mental health specialists. As a result, it will positively impact the foreseeable future.

Regionally, countries like India and China are growing in income, and many product-based businesses are developing health practices. Because of the rise in patients, healthcare professionals and corporate employees are affected. Furthermore, an increase in mental health activities in the healthcare sector to produce novel services and the existence of key players operating in the region contribute to the market's regional expansion.

KEY MARKET PLAYERS:

Companies playing a pivotal role in the Asia Pacific psychiatry therapies market are AstraZeneca, Universal Health Services Inc., Johnson & Johnson, Pfizer, GlaxoSmithKline, Eli Lilly, Bristol-Meyer Squibb, Wyeth, Astellas Pharma Inc., and others.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Social Psychology 

                                5.1.2 Abnormal Psychology         

                                5.1.3 Biological Psychology          

                                5.1.4 Other Types           

                                5.1.5  Y-o-Y Growth Analysis, By Type    

                                5.1.6  Market Attractiveness Analysis, By Type  

                                5.1.7  Market Share Analysis, By Type    

                5.2 Type of Medication                 

                                5.2.1 Antidepressants   

                                5.2.2 Antipsychotics       

                                5.2.3 Depressants           

                                5.2.4 Anxiolytics               

                                5.2.5 Mood Stabilisers   

                                5.2.6 Stimulants               

                                5.2.7 Other Types of Medication              

                                5.2.8 Y-o-Y Growth Analysis, By Type of Medication        

                                5.2.9 Market Attractiveness Analysis, By Type of Medication      

                                5.2.10 Market Share Analysis, By Type of Medication     

                5.3 Type of Therapy                       

                                5.3.1 Counselling             

                                5.3.2 Cognitive Behavioural Therapy       

                                5.3.3 Family Therapy      

                                5.3.4 Psychotherapy      

                                5.3.5 Group Therapy      

                                5.3.6 Relationship Counselling   

                                5.3.7 Interpersonal Therapy       

                                5.3.8 Behavioural Activation       

                                5.3.9 Other Types of Therapy    

                                5.3.10 Y-o-Y Growth Analysis, By Type of Therapy            

                                5.3.11  Market Attractiveness Analysis, By Type of Therapy         

                                5.3.12  Market Share Analysis, By Type of Therapy           

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Type

                                                6.1.3.2 By Type of Medication

                                                6.1.3.3 By Type of Therapy

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Type

                                                6.1.4.2 By Type of Medication

                                                6.1.4.3 By Type of Therapy

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Type

                                                6.1.5.2 By Type of Medication

                                                6.1.5.3 By Type of Therapy

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Astrazeneca                               

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Universal Health Services Inc.                             

                8.3 Johnson & Johnson                 

                8.4 Pfizer                            

                8.5 GlaxoSmithKline                       

                8.6 Eli Lilly                           

                8.7 Bristol-Meyer Squibb                             

                8.8 Wyeth                          

                8.9 Astellas Pharma Inc.                               

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by type, packaging and meat type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the North america market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Psychiatry Therapies Market, By Type , From 2021 to 2026 (USD Million)
  2. Asia Pacific Social Psychology Market, By Region, From 2021 to 2026 (USD Million)
  3. Asia Pacific Abnormal Psychology Market, By Region, From 2021 to 2026 (USD Million)
  4. Asia Pacific Biological Psychology Market, By Region, From 2021 to 2026 (USD Million)
  5. Asia Pacific Other Types Market, By Region, From 2021 to 2026 (USD Million)
  6. Asia Pacific Psychiatry Therapies Market, By Type of Medication , From 2021 to 2026 (USD Million)
  7. Asia Pacific Antidepressants Market, By Region, From 2021 to 2026 (USD Million)
  8. Asia Pacific Antipsychotics Market, By Region, From 2021 to 2026 (USD Million)
  9. Asia Pacific Depressants Market, By Region, From 2021 to 2026 (USD Million)
  10. Asia Pacific Anxiolytics Market, By Region, From 2021 to 2026 (USD Million)
  11. Asia Pacific Mood Stabilisers Market, By Region, From 2021 to 2026 (USD Million)
  12. Asia Pacific Stimulants  Market, By Region, From 2021 to 2026 (USD Million)
  13. Asia Pacific Other Types of Medication Market, By Region, From 2021 to 2026 (USD Million)
  14. Asia Pacific Psychiatry Therapies Market, By Type of Therapy , From 2021 to 2026 (USD Million)
  15. Asia Pacific Counselling Market, By Region, From 2021 to 2026 (USD Million)
  16. Asia Pacific Cognitive Behavioural Therapy Market, By Region, From 2021 to 2026 (USD Million)
  17. Asia Pacific Family Therapy Market, By Region, From 2021 to 2026 (USD Million)
  18. Asia Pacific Psychotherapy Market, By Region, From 2021 to 2026 (USD Million)
  19. Asia Pacific Group Therapy Market, By Region, From 2021 to 2026 (USD Million)
  20. Asia Pacific Relationship Counselling Market, By Region, From 2021 to 2026 (USD Million)
  21. Asia Pacific Interpersonal Therapy Market, By Region, From 2021 to 2026 (USD Million)
  22. Asia Pacific Behavioural Activation  Market, By Region, From 2021 to 2026 (USD Million)
  23. Asia Pacific Other Types of Therapy Market, By Region, From 2021 to 2026 (USD Million)
  24. Japan Psychiatry Therapies Market, By Type , From 2021 to 2026 (USD Million)
  25. Japan Psychiatry Therapies Market, By Type of Medication , From 2021 to 2026 (USD Million)
  26. Japan Psychiatry Therapies Market, By Type of Therapy , From 2021 to 2026 (USD Million)
  27. China Psychiatry Therapies Market, By Type , From 2021 to 2026 (USD Million)
  28. China Psychiatry Therapies Market, By Type of Medication , From 2021 to 2026 (USD Million)
  29. China Psychiatry Therapies Market, By Type of Therapy , From 2021 to 2026 (USD Million)
  30. India Psychiatry Therapies Market, By Type , From 2021 to 2026 (USD Million)
  31. India Psychiatry Therapies Market, By Type of Medication , From 2021 to 2026 (USD Million)
  32. India Psychiatry Therapies Market, By Type of Therapy , From 2021 to 2026 (USD Million)
  33. Australia Psychiatry Therapies Market, By Type , From 2021 to 2026 (USD Million)
  34. Australia Psychiatry Therapies Market, By Type of Medication , From 2021 to 2026 (USD Million)
  35. Australia Psychiatry Therapies Market, By Type of Therapy , From 2021 to 2026 (USD Million)
  36. South Korea Psychiatry Therapies Market, By Type , From 2021 to 2026 (USD Million)
  37. South Korea Psychiatry Therapies Market, By Type of Medication , From 2021 to 2026 (USD Million)
  38. South Korea Psychiatry Therapies Market, By Type of Therapy , From 2021 to 2026 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample